Jane Street’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $351K | Buy |
2,034
+25
| +1% | +$4.63K | ﹤0.01% | 8872 |
|
|
2025
Q4 | $401K | Buy |
2,009
+656
| +48% | +$119K | ﹤0.01% | 8191 |
|
|
2025
Q3 | $212K | Sell |
1,353
-38,075
| -97% | -$6.05M | ﹤0.01% | 9565 |
|
|
2025
Q2 | $5.98M | Sell |
39,428
-98,017
| -71% | -$13.1M | ﹤0.01% | 2769 |
|
|
2025
Q1 | $20.7M | Buy |
137,445
+101,109
| +278% | +$17M | 0.01% | 1265 |
|
|
2024
Q4 | $6.71M | Buy |
36,336
+4,620
| +15% | +$890K | ﹤0.01% | 2307 |
|
|
2024
Q3 | $6.25M | Buy |
31,716
+9,299
| +41% | +$1.93M | ﹤0.01% | 2505 |
|
|
2024
Q2 | $4.63M | Buy |
22,417
+5,280
| +31% | +$1.2M | ﹤0.01% | 3081 |
|
|
2024
Q1 | $4.64M | Buy |
17,137
+2,189
| +15% | +$523K | ﹤0.01% | 2725 |
|
|
2023
Q4 | $3.53M | Sell |
14,948
-1,363
| -8% | -$268K | ﹤0.01% | 3368 |
|
|
2023
Q3 | $3.2M | Sell |
16,311
-8,764
| -35% | -$1.8M | ﹤0.01% | 3277 |
|
|
2023
Q2 | $5.27M | Buy |
25,075
+2,962
| +13% | +$589K | ﹤0.01% | 2660 |
|
|
2023
Q1 | $4.46M | Buy |
22,113
+4,806
| +28% | +$1.09M | ﹤0.01% | 2605 |
|
|
2022
Q4 | $3.77M | Buy |
17,307
+4,807
| +38% | +$1.05M | ﹤0.01% | 2872 |
|
|
2022
Q3 | $2.46M | Buy |
+12,500
| New | +$2.7M | ﹤0.01% | 3829 |
|
|
2022
Q2 | – | Sell |
-8,376
| Closed | -$2.05M | – | 9781 |
|
|
2022
Q1 | $2.38M | Buy |
8,376
+1,562
| +23% | +$482K | ﹤0.01% | 4415 |
|
|
2021
Q4 | $2.57M | Buy |
6,814
+644
| +10% | +$250K | ﹤0.01% | 3983 |
|
|
2021
Q3 | $2.55M | Sell |
6,170
-4,597
| -43% | -$1.91M | ﹤0.01% | 3984 |
|
|
2021
Q2 | $3.98M | Buy |
10,767
+4,824
| +81% | +$1.61M | ﹤0.01% | 3045 |
|
|
2021
Q1 | $1.72M | Buy |
5,943
+201
| +4% | +$55.9K | ﹤0.01% | 4315 |
|
|
2020
Q4 | $1.44M | Sell |
5,742
-6,364
| -53% | -$1.52M | ﹤0.01% | 4072 |
|
|
2020
Q3 | $2.74M | Buy |
12,106
+10,780
| +813% | +$2.24M | ﹤0.01% | 2566 |
|
|
2020
Q2 | $231K | Buy |
+1,326
| New | +$212K | ﹤0.01% | 6192 |
|
|
2020
Q1 | – | Sell |
-3,628
| Closed | -$554K | – | 5366 |
|
|
2019
Q4 | $554K | Sell |
3,628
-2,434
| -40% | -$337K | ﹤0.01% | 3570 |
|
|
2019
Q3 | $802K | Buy |
6,062
+2,832
| +88% | +$380K | ﹤0.01% | 2909 |
|
|
2019
Q2 | $458K | Buy |
+3,230
| New | +$438K | ﹤0.01% | 3691 |
|
|
2019
Q1 | – | Sell |
-1,977
| Closed | -$224K | – | 5074 |
|
|
2018
Q4 | $224K | Sell |
1,977
-11,332
| -85% | -$1.42M | ﹤0.01% | 4377 |
|
|
2018
Q3 | $1.79M | Buy |
13,309
+8,025
| +152% | +$990K | ﹤0.01% | 2029 |
|
|
2018
Q2 | $593K | Buy |
+5,284
| New | +$571K | ﹤0.01% | 3404 |
|
|
2017
Q4 | – | Sell |
-2,416
| Closed | -$261K | – | 4632 |
|
|
2017
Q3 | $261K | Buy |
+2,416
| New | +$248K | ﹤0.01% | 3847 |
|
|
2017
Q1 | – | Sell |
-13,077
| Closed | -$996K | – | 4189 |
|
|
2016
Q4 | $996K | Buy |
13,077
+10,038
| +330% | +$762K | ﹤0.01% | 2080 |
|
|
2016
Q3 | $253K | Buy |
+3,039
| New | +$255K | ﹤0.01% | 3470 |
|
|
2016
Q2 | – | Sell |
-5,225
| Closed | -$397K | – | 4122 |
|
|
2016
Q1 | $397K | Sell |
5,225
-37,765
| -88% | -$2.8M | ﹤0.01% | 2861 |
|
|
2015
Q4 | $3.46M | Buy |
42,990
+28,554
| +198% | +$2.06M | 0.02% | 681 |
|
|
2015
Q3 | $917K | Buy |
+14,436
| New | +$1.04M | 0.01% | 1708 |
|
|
2015
Q2 | – | Sell |
-8,270
| Closed | -$656K | – | 3665 |
|
|
2015
Q1 | $656K | Buy |
+8,270
| New | +$610K | 0.01% | 1764 |
|
|
2014
Q2 | – | Sell |
-10,859
| Closed | -$655K | – | 2617 |
|
|
2014
Q1 | $655K | Buy |
+10,859
| New | +$633K | 0.01% | 1323 |
|
|
2013
Q4 | – | Sell |
-50,008
| Closed | -$2.31M | – | 2413 |
|
|
2013
Q3 | $2.31M | Buy |
50,008
+36,784
| +278% | +$1.69M | 0.03% | 506 |
|
|
2013
Q2 | $543K | Buy |
+13,224
| New | +$567K | 0.01% | 1375 |
|
Other funds holding CRL
VCM
VPM
Jane Street's CRL Position: Q1 2026 in Review
Jane Street increased its Charles River Laboratories (CRL) stake by 1.2% in Q1 2026, buying an estimated $4.63K and bringing the position to 2,034 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #8872.
Jane Street first reported a position in CRL in Q2 2013 and has held it in 39 quarters since. The position peaked at $20.7M in Q1 2025. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Jane Street held 2,034 shares of Charles River Laboratories worth $351K as of Q1 2026.
- Jane Street bought 25 Charles River Laboratories shares in Q1 2026, an estimated $4.63K.
- Charles River Laboratories made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8872 holding.
- Jane Street first reported a position in Charles River Laboratories in Q2 2013 and has held it in 39 quarters since.
- Jane Street's Charles River Laboratories position peaked at $20.7M in Q1 2025.
- 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.